Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Current Rheumatology Reports|May 15, 2012
Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?Marilyn C Pike, Lexy KelleyRheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.Annals of the Rheumatic Diseases|January 15, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre studyDaniel J Wallace, Kenneth Kalunian, Michelle A Petri, et al.Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.Pageof 1